- (a) The chief executive shall establish a written policy that prohibits the use of detainees for medical, pharmaceutical, or cosmetic experiments.
- (b) The policy should not preclude individualized treatment of a detainee based on his or her needs for a specific medical procedure which is not generally available, nor should it prohibit testing of detainees for communicable or contagious disease or illness.
- (c) This policy should not prohibit the administration of treatments or drugs with a federal emergency use authorization.